7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,884.81

+609.74

+0.79%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

Tokyo - Delayed Quote JPY

Shionogi & Co., Ltd. (4507.T)

3,012.00 +23.00 (+0.77%)

At close: October 30 at 3:30:00 PM GMT+9

SGIOY vs. UTHR: Which Stock Is the Better Value Option?

Zacks 1d ago

UTHR

4507.T
+0.77%
SGIOF
Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) Q2 Earnings Lag Estimates

Zacks 3d ago

4507.T
+0.77%
SGIOF

NRXP
How Investors Are Reacting To Shionogi (TSE:4507) Clinical Trial Results

Simply Wall St. 6d ago

4507.T
+0.77%
4507
IDWeek 2026: Shionogi Presents U.S. Analysis of Real-World Data Showing Early Treatment Initiation with Fetroja®/Fetcroja® (cefiderocol) Improved Clinical Outcomes in Patients with Respiratory Infections

Business Wire 11d ago

4507.T
+0.77%
Shionogi and F2G’s invasive aspergillosis drug shows long-term benefit

Clinical Trials Arena 11d ago

4507.T
+0.77%
Shionogi & Co. (SGIOY) Upgraded to Buy: Here's What You Should Know

Zacks 17d ago

4507.T
+0.77%
SGIOF
Can Shionogi (TSE:4507) Support Its Price With Earnings After IntraBio?

Simply Wall St. 22d ago

4507.T
+0.77%
4507
Shionogi bolsters rare disease portfolio with $2bn IntraBio buyout

Pharmaceutical Technology 26d ago

4507.T
+0.77%
Shionogi acquires rare disease startup IntraBio for $2 billion

Quartz 26d ago

4507.T
+0.77%
Shionogi pays $2B to acquire a rare disease startup

BioPharma Dive 26d ago

4507.T
+0.77%
Shionogi Continues Rare Disease Expansion With Planned Acquisition of IntraBio Inc.

Business Wire 27d ago

4507.T
+0.77%
Shionogi & Co Ltd's Dividend Analysis

GuruFocus.com 1mo ago

4507.T
+0.77%
SGIOF

Mobilize your Website

View Site in Mobile | Classic

Share by: